The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Juror in glyphosate-cancer trial urges judge to uphold $80 million verdict appealed by Bayer

| | July 9, 2019

A juror who was part of a panel that delivered an $80 million award against Bayer AG after finding that its glyphosate-based weed killer Roundup caused a man’s cancer has urged the presiding judge to uphold the decision.

Following a four-week trial, a federal jury on March 27 awarded $5 million in compensatory and $75 million in punitive damages to Edwin Hardeman, who was diagnosed with non-Hodgkin’s lymphoma in 2014.

In the letter, the unidentified juror told U.S. District Judge Vince Chhabria in San Francisco that the $80 million in awards “were no accident” and the result of “meticulous planning” by the jury.

Related article:  South American farmers increasing acreage of Monsanto's new GMO soy

The letter was a response to statements by Chhabria during a court hearing …. when the judge said he would have to reduce the $75 million punitive damages portion of the award on constitutional grounds.

Read full, original article: Juror urges U.S. judge to uphold $80 million Roundup verdict against Bayer

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend